Related Experiment Videos
[Vascular gene therapy--the choice of procedures as a function of strategies]
R De Caterina1, M G Colombo, J Gianetti
1Istituto di Fisiologia Clinica, CNR, Pisa. rdecater@po.ifc.pi.cnr.it
Cardiologia (Rome, Italy)
|April 3, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Exercise pulmonary hypertension in asymptomatic patients with HIV infection Insights from the RIGHT-NET registry.
European journal of internal medicine·2026
Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.
International journal of cardiology·2026
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2021
State of play and future direction with NOACs: An expert consensus.
Vascular pharmacology·2018
Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study.
European heart journal. Cardiovascular Imaging·2017
APOBEC3 Knockout in Lentiviral Packaging Cells Improves Therapeutic Transgene Sequence Fidelity.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
PRDM16 as a Multifaceted Pharmacological Target in Kidney Diseases: From Epigenetic Mechanisms to Therapeutic Strategies.
Pharmaceuticals (Basel, Switzerland)·2026
Olmesartan-Loaded PLGA Nanoparticles Attenuate Methotrexate-Induced Kidney Injury: Association with the AT1R/ERK1/2 Signaling Axis.
Pharmaceuticals (Basel, Switzerland)·2026